PYT OE TL 2.5773 / 2.8626/ AT0000A2GDW1 /
6/10/2024 4:03:52 PM | Chg.0.000 | Bid4:03:52 PM | Ask6/10/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.100EUR | 0.00% | 0.100 Bid Size: - |
0.110 Ask Size: - |
POLYTEC HLDG AG INH.... | 2.5773 EUR | 12/31/2078 | Call |
GlobeNewswire
12:24 AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Xiao-I Corporation Investors to Inquire About Securities...
GlobeNewswire
12:19 AM
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Perion Network Ltd. Inv...
GlobeNewswire
12:15 AM
Centurion Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
GlobeNewswire
12:13 AM
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before...
GlobeNewswire
12:00 AM
GICAI launches revolutionary global digital currency quantitative trading platform to improve invest...
GlobeNewswire
6/10
Empower Healthcare Solutions and DispatchHealth® collaborate to bring in-home urgent medical care to...
GlobeNewswire
6/10
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primar...
GlobeNewswire
6/10
Atour Lifestyle Holdings Limited Announces Proposed Registered Secondary Offering of American Deposi...
GlobeNewswire
6/10
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Hertz Global Holdings, Inc. Investors to Secure Counsel B...
GlobeNewswire
6/10
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
6/10
Bitfarms Announces Toronto Stock Exchange Deferral of Consideration of Shareholder Rights Plan
GlobeNewswire
6/10
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to...
GlobeNewswire
6/10
Inception Growth Acquisition Limited Announces Extension of Business Combination Period and Addition...
GlobeNewswire
6/10
CANON UNVEILS THE FUTURE OF EVERYDAY VR CONTENT CREATION WITH NEW DUAL FISHEYE LENS
GlobeNewswire
6/10
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primar...